Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome

Thalidomide is effective for treating the oral and genital ulcers and follicular lesions of the Behçet syndrome. A dosage of 100 mg/d is as effective as a dosage of 300 mg/day.